{"top_spans": [[0, 0], [1, 1], [3, 3], [6, 6], [6, 7], [11, 11], [11, 16], [13, 16], [13, 17], [13, 18], [15, 17], [22, 22], [24, 24], [26, 26], [26, 28], [28, 28], [34, 34], [35, 38], [40, 45], [50, 50], [52, 52], [60, 60], [61, 61], [63, 69], [63, 70], [64, 70], [65, 70], [66, 70], [70, 70], [71, 72], [73, 73], [75, 75], [80, 82]], "predicted_antecedents": [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 5, -1, -1, -1, 9, -1, -1, -1, 7, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1], "document": ["genmab", "announces", "positive", "topline", "results", "in", "phase", "iii", "maia", "study", "of", "daratumumab", "in", "front", "line", "multiple", "myeloma", "phase", "iii", "maia", "study", "of", "daratumumab", "in", "combination", "with", "lenalidomide", "and", "dexamethasone", "in", "front", "line", "multiple", "myeloma", "met", "the", "primary", "endpoint", "pfs", "at", "a", "pre", "-", "planned", "interim", "analysis", "demonstrating", "the", "superiority", "of", "drd", "over", "rd", "independent", "data", "monitoring", "committee", "janssen", "biotech", "inc", "genmab", "genmab", "genmab", "lenalidomide", "front", "line", "multiple", "myeloma", "multiple", "myeloma", "genmab", "a", "s", "united", "states", "darzalex", "chief", "executive", "officer", "of", "genmab", "daratumumab", "dexamethasone"], "clusters": [[[11, 11], [22, 22], [28, 28], [50, 50]]]}